EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 323 filers reported holding EXELIXIS INC in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $29,471,000 | -7.9% | 1,300,000 | -25.7% | 7.12% | +0.2% |
Q4 2021 | $31,990,000 | -0.8% | 1,750,000 | +14.8% | 7.11% | -5.3% |
Q3 2021 | $32,239,000 | +26.9% | 1,525,000 | +9.4% | 7.51% | +40.9% |
Q2 2021 | $25,401,000 | -6.4% | 1,394,107 | +16.1% | 5.33% | -5.0% |
Q1 2021 | $27,133,000 | +184.6% | 1,201,100 | +152.9% | 5.61% | +262.3% |
Q4 2020 | $9,533,000 | +74.1% | 475,000 | +53.4% | 1.55% | +207.8% |
Q3 2019 | $5,477,000 | -85.1% | 309,700 | -85.1% | 0.50% | -91.2% |
Q3 2018 | $36,769,000 | -6.9% | 2,075,000 | +13.1% | 5.73% | +4.7% |
Q2 2018 | $39,485,000 | -99.8% | 1,834,793 | +103.9% | 5.47% | +84.9% |
Q1 2018 | $19,933,000,000 | +79657.5% | 899,900 | -71.9% | 2.96% | -58.6% |
Q2 2016 | $24,992,000 | +60.4% | 3,200,000 | -17.9% | 7.16% | +28.0% |
Q1 2016 | $15,584,000 | +36.0% | 3,896,113 | +91.7% | 5.59% | +16.3% |
Q4 2015 | $11,463,000 | +28.5% | 2,032,494 | +27.8% | 4.81% | +36.3% |
Q3 2015 | $8,920,000 | +218.5% | 1,590,000 | +113.4% | 3.53% | +223.1% |
Q2 2015 | $2,801,000 | -12.9% | 745,000 | -66.6% | 1.09% | -29.5% |
Q4 2014 | $3,217,000 | -58.8% | 2,233,711 | -56.2% | 1.55% | -53.8% |
Q3 2014 | $7,803,000 | – | 5,100,000 | – | 3.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |